Hum. Reprod. Advance Access originally published online on April 7, 2005
Human Reproduction 2005 20(8):2211-2214; doi:10.1093/humrep/dei020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study
1 Department of Obstetrics and Gynecology, University of Oulu, 2 Infertility Clinic, Family Federation of Finland, 90220 Oulu, 3 Department of Obstetrics and Gynecology, University of Kuopio, 70211 Kuopio and 4 Department of Obstetrics and Gynecology, University of Tampere, 33521 Tampere, Finland
5 To whom correspondence should be addressed. Email: mervi.pakkila{at}oulu.fi
BACKGROUND: Poor ovarian and endometrial responses to gonadotrophin stimulation in assisted reproduction techniques lead to decreased pregnancy rates. The aim of the present study was to test the hypothesis that low-dose aspirin started prior to controlled ovarian stimulation improves ovarian responsiveness, pregnancy rate (PR) and pregnancy outcome. METHODS: A total of 374 women who were to undergo IVF/ICSI were randomized to receive 100 mg of aspirin (n=186) or placebo (n=188) daily. Treatment was started on the first day of controlled ovarian stimulation. It was continued until menstruation or a negative pregnancy test. Pregnant women continued the medication until delivery. The main outcome measures were the number of oocytes, number and quality of embryos, the clinical PR and pregnancy outcome. RESULTS: The mean (±SD) number of oocytes (12.0±7.0 versus 12.7±7.2), the total mean number of embryos (5.82±4.35 versus 5.99±4.66), the mean number of top quality embryos (0.99±1.39 versus 1.18±1.51) and the number of embryos transferred (1.64±0.64 versus 1.63±0.71) did not differ in the aspirin and placebo groups. Between the aspirin and placebo group, there was no statistically significant difference in clinical PR per embryo transfer (25.3%, n=44 out of 174 versus 27.4%, n=48 out of 175) or clinical PR per cycle initiated (23.7% versus 25.5%). Birth rate per embryo transfer did not differ significantly between the aspirin (18.4%) and placebo (21.1%) groups. The incidence of poor responders [12 (6.5%) versus 13 (6.9%)] was similar in both groups. CONCLUSIONS: The present results indicate that low-dose aspirin treatment does not have any beneficial effect on ovarian responsiveness, PR and pregnancy outcome in unselected women undergoing IVF/ICSI.
Key words: ICSI/IVF/low-dose aspirin/ovarian response/pregnancy rate
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Haapsamo, H. Martikainen, and J. Rasanen Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI: a randomized, placebo-controlled, double-blind study Hum. Reprod., April 1, 2009; 24(4): 861 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.A. Gelbaya, M. Kyrgiou, T.C. Li, C. Stern, and L.G. Nardo Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis Hum. Reprod. Update, July 1, 2007; 13(4): 357 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Achache and A. Revel Endometrial receptivity markers, the journey to successful embryo implantation Hum. Reprod. Update, November 1, 2006; 12(6): 731 - 746. [Abstract] [Full Text] [PDF]
|
|